Omvoh
These highlights do not include all the information needed to use OMVOH safely and effectively. See full prescribing information for OMVOH. OMVOH (mirikizumab-mrkz) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2023
472cbe04-263e-433d-9a0f-58c1b50b715a
HUMAN PRESCRIPTION DRUG LABEL
Nov 6, 2023
Eli Lilly and Company
DUNS: 006421325
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
mirikizumab-mrkz
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
mirikizumab-mrkz
Product Details
FDA regulatory identification and product classification information